Skip to main content

Advertisement

Log in

Fibromyalgia: a rheumatologic diagnosis?

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Fibromyalgia (FM) is a medically unexplained or functional somatic syndrome (FSS). The two classification criteria are chronic widespread pain (CWP) and the finding of 11/18 tender points (TP). FM overlaps and co-occurs with other FSSs, and auxiliary symptoms that are not included in the criteria may be clues to other FSSs. About ten FSSs include chronic fatigue syndrome, myofascial pain syndromes and irritable bowel syndrome. TP do not reflect demonstrable pathology, and are locations where everyone is generally more tender. In FM they are more tender than normal due to lowered pain threshold. High TP counts are associated with the extent of distress or unspecific somatic symptoms in the absence of chronic pain. TP lack validity and should be excluded. CWP and distress are outside the domain of rheumatology, and abnormal mechanisms in FM relate to the central nervous system, as compared to “peripheral” mechanisms studied in rheumatology. FM should not be considered as a rheumatologic condition but rather as part of a broader spectre of FSSs. Patients with FSSs should be considered and treated together across medical specialities by general physicians in primary health care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Winfried Häuser, Jacob Ablin, … Brian Walitt

References

  1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33:160–172

    Article  PubMed  CAS  Google Scholar 

  2. Wolfe F (1996) The fibromyalgia syndrome: a consensus report on fibromyalgia and disability. J Rheumatol 23:534–539

    PubMed  CAS  Google Scholar 

  3. Goldenberg DL (1999) Fibromyalgia syndrome a decade later: what have we learned? Arch Intern Med 159:777–785

    Article  PubMed  CAS  Google Scholar 

  4. Aaron LA, Buchwald D (2001) A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med 134:868–881

    PubMed  CAS  Google Scholar 

  5. Aaron LA, Buchwald D (2003) Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions. Baillieres Best Pract Res Clin Rheumatol 17:563–574

    Article  Google Scholar 

  6. Wessely S, Nimnuan C, Sharpe M (1999) Functional somatic syndromes: one or many? Lancet 354:936–939

    Article  PubMed  CAS  Google Scholar 

  7. Nimnuan C, Rabe-Hesketh S, Wessely S, Hotopf M (2001) How many functional syndromes? J Psychosom Res 51:549–557

    Article  PubMed  CAS  Google Scholar 

  8. McBeth J, Macfarlane GJ, Hunt IM, Silman AJ (2001) Risk factors for persistent chronic widespread pain: a community-based study. Rheumatology 40:95–101

    Article  PubMed  CAS  Google Scholar 

  9. White KP, Nielson WR, Harth M, Ostbye T, Speechley M (2002) Chronic widespread musculoskeletal pain with or without fibromyalgia: psychological distress in a representative community adult sample. J Rheumatol 29:588–594

    PubMed  Google Scholar 

  10. Gran JT (2003) The epidemiology of chronic generalized musculoskeletal pain. Baillieres Best Pract Res Clin Rheumatol 17:547–561

    Article  Google Scholar 

  11. Henningsen P, Zimmermann T, Sattel H (2003) Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med 65:528–533

    Article  PubMed  Google Scholar 

  12. Croft P, Schollum J, Silman A (1994) Population study of tender point counts and pain as evidence of fibromyalgia. BMJ 309:696–699

    PubMed  CAS  Google Scholar 

  13. Croft P, Burt J, Schollum J, Thomas E, Macfarlane G, Silman A (1996) More pain, more tender points: is fibromyalgia just one end of a continuous spectrum? Ann Rheum Dis 55:482–485

    Article  PubMed  CAS  Google Scholar 

  14. Simms RW (1998) Fibromyalgia is not a muscle disorder. Am J Med Sci 315:346–350

    Article  PubMed  CAS  Google Scholar 

  15. Le Goff P (2006) Is fibromyalgia a muscle disorder? Joint Bone Spine 73:239–242

    Article  PubMed  Google Scholar 

  16. Granges G, Littlejohn GO (1993) A comparative study of clinical signs in fibromyalgia/fibrositis syndrome, healthy and exercising subjects. J Rheumatol 20:344–351

    PubMed  CAS  Google Scholar 

  17. Lautenbacher S, Rollman GB, McCain GA (1994) Multi-method assessment of experimental and clinical pain in patients with fibromyalgia. Pain 59:45–53

    Article  PubMed  CAS  Google Scholar 

  18. Gracely RH, Grant MA, Giesecke T (2003) Evoked pain measures in fibromyalgia. Baillieres Best Pract Res Clin Rheumatol 17:593–609

    Article  Google Scholar 

  19. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38:19–28

    Article  PubMed  CAS  Google Scholar 

  20. Wolfe F, Ross K, Anderson J, Russell IJ (1995) Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol 22:151–156

    PubMed  CAS  Google Scholar 

  21. Pearce JM (2004) Myofascial pain, fibromyalgia or fibrositis? Eur Neurol 52:67–72

    Article  PubMed  CAS  Google Scholar 

  22. Wolfe F (2003) Stop using the American College of Rheumatology criteria in the clinic. J Rheumatol 30:1671–1672

    PubMed  Google Scholar 

  23. Schochat T, Raspe H (2003) Elements of fibromyalgia in an open population. Rheumatology 42:829–835

    Article  PubMed  CAS  Google Scholar 

  24. Wolfe F, Skevington SM (2000) Measuring the epidemiology of distress: the rheumatology distress index. J Rheumatol 27:2000–2009

    PubMed  CAS  Google Scholar 

  25. Wolfe F (1997) The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis 56:268–271

    PubMed  CAS  Google Scholar 

  26. Guidelines for the development of practice guidelines. American College of Rheumatology (1998). Available through http://www.rheumatology.org

  27. Clauw DJ, Crofford LJ (2003) Chronic widespread pain and fibromyalgia: what we know, and what we need to know. Baillieres Best Pract Res Clin Rheumatol 17:685–701

    Article  Google Scholar 

  28. Katz RS, Wolfe F, Michaud K (2006) Fibromyalgia diagnosis: a comparison of clinical, survey, and American College of Rheumatology criteria. Arthritis Rheum 54:169–176

    Article  PubMed  Google Scholar 

  29. Burckhardt CS, Clark SR, Bennett RM (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18:728–733

    PubMed  CAS  Google Scholar 

  30. Wolfe F, Hawley DJ, Goldenberg DL, Russel IJ, Buskila D, Neumann L (2000) The assessment of functional impairment in fibromyalgia (FM): Rasch analyses of 5 functional scales and the development of the FM Health Assessment Questionnaire. J Rheumatol 27:1989–1999

    PubMed  CAS  Google Scholar 

  31. Clauw DJ (1995) The pathogenesis of chronic pain and fatigue syndromes, with special reference to fibromyalgia. Med Hypotheses 44:369–378

    Article  PubMed  CAS  Google Scholar 

  32. Evengard B, Klimas N (2002) Chronic fatigue syndrome: probable pathogenesis and possible treatments. Drugs 62:2433–2446

    Article  PubMed  Google Scholar 

  33. Cho HJ, Skowera A, Cleare A, Wessely S (2006) Chronic fatigue syndrome: an update focusing on phenomenology and pathophysiology. Curr Opin Psychiatry 19:67–73

    Article  PubMed  Google Scholar 

  34. Farber L, Haus U, Spath M, Drechsler S (2004) Physiology and pathophysiology of the 5-HT3 receptor. Scand J Rheumatol Suppl 119:2–8

    PubMed  Google Scholar 

  35. Geracioti TD Jr, Carpenter LL, Owens MJ, Baker DG, Ekhator NN, Horn PS, Strawn JR, Sanacora G, Kinkead B, Price LH, Nemeroff CB (2006) Elevated cerebrospinal fluid substance P concentrations in posttraumatic stress disorder and major depression. Am J Psychiatry 163:637–643

    Article  PubMed  Google Scholar 

  36. Owens MJ, Nemeroff CB (1994) Role of serotoin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 40:288–295

    PubMed  CAS  Google Scholar 

  37. Legangneux E, Mora JJ, Spreux-Varoquaux O, Thorin I, Herrrou M, Alvado G, Gomeni C (2001) Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome. Rheumatology 40:290–296

    Article  PubMed  CAS  Google Scholar 

  38. Axelson DA, Perel JM, Birmaher B, Rudolph G, Nuss S, Yurasits L, Bridge J, Brent DA (2005) Platelet serotonin reuptake inhibition and response to SSRIs in depressed adolescents. Am J Psychiatry 162:802–804

    Article  PubMed  Google Scholar 

  39. Goldenberg DL, Burckhardt C, Crofford L (2004) Management of fibromyalgia syndrome. JAMA 292:2388–2395

    Article  PubMed  CAS  Google Scholar 

  40. Evengard B, Nilsson CG, Lindh G, Lindquist L, Eneroth P, Fredrikson S, Terenius L, Henriksson KG (1998) Chronic fatigue syndrome differs from fibromyalgia: no evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome. Pain 78:153–155

    Article  PubMed  CAS  Google Scholar 

  41. Lindh C, Liu Z, Lyrenas S, Ordeberg G, Nyberg F (1997) Elevated cerebrospinal fluid substance P-like immunoreactivity in patients with painful osteoarthritis, but not in patients with rhizopatic pain from a herniated lumbar disc. Scand J Rheumatol 26:468–472

    Article  PubMed  CAS  Google Scholar 

  42. De Stefano R, Selvi E, Villanova M, Frati E, Manganelli S, Franceschini E, Biasi G, Marcolongo R (2000) Image analysis quantification of substance P immunoreactivity in the trapezius muscle of patients with fibromyalgia and myofascial pain syndrome. J Rheumatol 27:2906–2910

    PubMed  Google Scholar 

  43. Goldberg J, Davidson P (1997) A biopsychosocial understanding of the irritable bowel syndrome: a review. Can J Psychiatry 42:835–840

    PubMed  CAS  Google Scholar 

  44. Tsigos C, Chrousos GP (2002) Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 53:865–871

    Article  PubMed  Google Scholar 

  45. Riedel W, Schlapp U, Leck S, Netter P, Neeck G (2002) Blunted ACTH and cortisol responses to systemic injection of corticotropin-releasing hormone (CRH) in fibromyalgia: role of somatostatin and CRH-binding protein. Ann NY Acad Sci 966:483–490

    Article  PubMed  CAS  Google Scholar 

  46. Cleare AJ (2003) The neuroendocrinology of chronic fatigue syndrome. Endocr Rev 24:236–252

    PubMed  CAS  Google Scholar 

  47. Mayer EA, Craske M, Naliboff BD (2001) Depression, anxiety, and the gastrointestinal system. J Clin Psychiatry 62(Suppl 8):28–36

    PubMed  Google Scholar 

  48. Mease PJ, Clauw DJ, Arnold LM, Goldenberg DL, Witter J, Williams DA, Simon LS, Strand CV, Bramson C, Martin S, Wright TM, Littman B, Wernicke JF, Gendreau RM, Crofford LJ (2005) Fibromyalgia syndrome. J Rheumatol 32:2270–2277

    PubMed  Google Scholar 

  49. Kroenke K, Spitzer RL, deGruy FV III, Swindle R (1998) A symptom checklist to screen for somatoform disorders in primary care. Psychosomatics 39:263–272

    PubMed  CAS  Google Scholar 

  50. Aggarwal VR, McBeth J, Zakrzewska JM, Lunt M, Macfarlane GJ (2006) The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors? Int J Epidemiol 35:468–476

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gerhard K. M. Endresen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Endresen, G.K.M. Fibromyalgia: a rheumatologic diagnosis?. Rheumatol Int 27, 999–1004 (2007). https://doi.org/10.1007/s00296-007-0402-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-007-0402-x

Keywords

Navigation